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Abstract 
One consequence of the internationalisation of R&D may be the transfer of foreign 
technology from the multinational to other firms in its home country. This phenomenon, 
which can be termed inter-firm reverse technology transfer and which has not been directly 
analysed by either the international management or foreign direct investment literature, may 
have significant implications for policy – particularly in Europe. This paper is a first attempt 
in this direction. Patent citation analysis on a database of EPO patents granted to 17 European 
chemical and pharmaceutical multinationals over the period 1985-05 shows that they act as a 
channel for the transmission of knowledge developed in the US, to other home country firms; 
these results are robust to the exclusion of examiner citations. We find that this technology 
transfer process is explained by the degree of home country embeddedness of the 
multinational firm, the US subsidiaries’ engagement in asset-augmenting activities, and the 
presence of a technology gap between the US and the home country. These results point to an 
alternative understanding of foreign direct R&D investment and its implications for the home 
country’s technological activity and general competitive performance. 
Keywords: reverse technology transfer; R&D internationalisation; multinational firms; patent 
citation; embeddedness. 
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Inter-firm reverse technology transfer:  
The home country effects of R&D internationalisation 
 
1. Introduction 
Multinational enterprises (MNEs) play a dominant role in innovation activities in their 
home countries, and control a large proportion of the world’s stock of advanced 
technologies. Their decisions regarding the method, location and exploitation of 
research and development (R&D) can greatly influence the home country’s 
technological potential and competitiveness (Pavitt and Patel, 1999); thus, the 
growing internationalisation of R&D activity has been a cause of concern to 
policymakers. In Europe it has been suggested that the relocation abroad of R&D– 
particularly in the faster growing industries –is resulting in a ‘hollowing out’ of 
domestic capabilities and a weakening of the national innovation system (ETAN, 
1998). In the US the internationalisation of industrial R&D has brought worries about 
a possible impoverishment of the national technology base due to the increased R&D 
activities of foreign MNEs (Kogut and Chang, 1991).  
However, whether these concerns are justified can only be decided by evaluating 
the nature and extent of the R&D activity that has been relocated abroad. Policy 
makers may relaxed about simple adaptations to products developed at home to suit 
local tastes, but should be concerned about the transfer of more substantive R&D 
investment. Even then, the problem is not so much the extent of the R&D performed 
abroad, but the extent to which the domestic economy benefits from it, if at all. Indeed 
foreign subsidiaries’ innovative efforts may increase domestic technological 
competitiveness if what is absorbed abroad spills over to other home country firms.  
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This process, defined by Mansfield and Romeo (1980) as ‘reverse technology 
transfer’ (RTT), is not new (Reddaway et al., 1968), but it has mainly been examined 
as a means of improving the MNE’s knowledge and technology assets portfolios (i.e. 
intra-firm reverse technology transfer - see Mansfield and Romeo, 1980; Gupta and 
Govindarajan, 2000; Frost and Zhou, 2005; Singh, 2007) and its productivity (Fors, 
1997; Griffith et al., 2006). But reverse technology transfer can have significant 
effects on the home country if the knowledge and resources that are transferred back 
to the parent firm spill over to the rest of the economy through linkages with domestic 
firms – i.e. inter-firm RTT.  
Despite the political relevance of the potential reverse flow of knowledge from 
R&D activities performed abroad, this process has not received explicit research 
attention in the academic literature. The R&D internationalisation literature generally 
regards the home country as the source of an MNE’s technological advantage (e.g. 
Sölvell et al., 1991) and thus it assumes that internationalisation entails only outflows 
of knowledge. The foreign direct investment (FDI) literature mainly focuses on the 
impact of outward investment (primarily, foreign production) on home-country 
employment and balance of payments, disregarding the effects on the technology 
base. The effect of outward FDI on the home country’s productivity and knowledge 
base has also been rather ignored (van Pottelsberghe de la Potterie and Lichtenberg, 
2001). For example, in a recent survey, Lipsey (2002) does not mention a single study 
investigating either of these issues. As Blomström and Kokko (1998: 22) 
acknowledge, ‘the existing literature on the home country effects of FDI has seldom 
referred explicitly to spillovers’ (emphasis added). Thus, there has been little direct 
investigation of inter-firm RTT. One of the few quantitative studies of this process is 
by Globerman et al. (2000), who carry out citation analysis on a sample of Swedish 
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patents and find that the pattern of Swedish outward FDI is a significant determinant 
of the knowledge flows to Sweden.  
Our study aims to contribute to the research on the impact on the home country of 
R&D internationalisation, by testing for the presence of inter-firm RTT stemming 
from the activities of the US subsidiaries of 17 European chemical and 
pharmaceutical MNEs over the period 1985-2005. Following Globerman et al. 
(2000), we track international knowledge flows through citation analysis for a sample 
of European Patent Office (EPO) patents. We demonstrate empirically that the main 
factor favouring the realisation of technology-related externalities from outward FDI 
is high degree of embeddedness of MNEs in their home countries. Despite greater 
internationalisation, MNEs remain strongly embedded in their home countries where 
they are at the centre of dense networks of relationships with suppliers, customers, 
competitors, research institutes and universities, financial institutions and industry 
associations (Sally, 1994). 
Section 2 describes the theoretical background underpinning the RTT process. 
Section 3 discusses the limitations of patent data to measure innovative activity in US 
subsidiaries, and of patent citation analysis to track knowledge flows. Section 4 
describes the data and Section 5 illustrates the empirical approaches used to test for 
the presence of inter-firm RTT and reports and explains the empirical findings. 
Section 6 tests for the factors influencing this technology transfer process; Section 7 
elaborates the results and offers some conclusions. 
 
2. Theoretical framework 
Traditionally, the main function of foreign R&D has been considered to be support for 
local production and sales activities through the adaptation of technology invented at 
home to local market conditions (e.g. Vernon, 1966). Technology transfer was seen as 
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predominantly from headquarters to foreign subsidiaries, and R&D was considered to 
be primarily asset-exploiting (Dunning and Narula, 1995), incremental and associated 
with demand-driven innovative activities. However, increasingly R&D activities are 
being located abroad to augment existing and acquire new technological assets from 
the local knowledge base (public infrastructure or sector specific agglomeration 
effects) or specific firms (Kuemmerle, 1999). The growing importance of these types 
of asset-augmenting (Dunning and Narula, 1995) R&D facilities is stimulating 
theoretical and empirical research on the processes and mechanisms through which 
knowledge produced in foreign R&D units is transferred back to the parent company 
or other foreign subsidiaries i.e. intra-firm RTT (Gupta and Govindarajan, 2000; Frost 
and Zhou, 2005; Singh, 2007).  
The ability to acquire knowledge from pockets of excellence around the world and 
to manage knowledge flows within international networks of interdependent and 
specialised units, is now considered the main source of competitive advantage for 
MNEs (Bartlett and Ghoshal, 1989; Kogut and Zander, 1993). Building an 
evolutionary theory of the firm, Kogut and Zander (1993) define MNEs as ‘social 
communities that specialize in the creation and internal transfer of knowledge’ 
According to them ‘a MNE arises not out of the market failures for the buying and 
selling of knowledge but out of its superior efficiency as an organizational vehicle by 
which knowledge is transferred across borders’ (Kogut and Zander, 1993: 625). 
MNEs, therefore, are firms that are specialised in cross-border technology transfer of 
relatively tacit and idiosyncratic knowledge, and their survival and expansion are 
determined by their ability and efficiency in this task. The specific ability of MNEs to 
articulate tacit knowledge implies that if foreign affiliates can absorb this knowledge, 
the MNE will be able to codify and exploit it within the firm. This ‘encoding’ of the 
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knowledge makes it more easily imitable by other firms in the home country once it 
has been transferred back to the parent company.  
Although there are barriers to the internal diffusion of knowledge associated with 
its characteristics, the prior knowledge of the receiving unit, and the willingness of a 
unit to share information with other units (Sölvell and Zander, 1995; Gupta and 
Govindarajan, 2000), studies on intra-firm RTT have found that even though the more 
traditional knowledge flows, from the centre to the periphery, continue to be 
dominant, reverse flows are an increasing phenomenon (Gupta and Govindarajan, 
2000; Frost and Zhou, 2005; Singh, 2007). These studies show that knowledge flows 
from foreign units to the parent company will be more likely if foreign affiliates 
undertake asset-augmenting types of activities, which generate knowledge that is less 
context-specific and thus more useful to the rest of the organisation. In addition, 
Gupta and Govindarajan (2000) show that the wider the technology gap between the 
host and home countries, the greater the incidence of reverse knowledge flows.  
The emphasis in these studies is on the MNE rather than other home country firms 
and institutions. But, as Globerman (1994) points out, there may be some public 
effects associated with these private effects of outward FDI (i.e. effects on the home 
country as a whole) if the benefits of these activities are not completely captured by 
the MNE.1 One obvious social benefit is improved technological performance and 
                                                 
1 Although this study focuses on the benefits from relocating R&D abroad, there are some negative 
externalities from this type of outward FDI. E.g., there could be a reduction in the investing MNE’s 
home country knowledge intensive activities, the so called ‘hollowing out’ effect (ETAN 1998), or 
successful imitation by foreign competitors of technologies and innovations. As a result of potential 
leakage effects from the presence of home country affiliates in foreign markets, MNEs may suffer 
reduced sales in both the foreign and home markets, which may provoke decreased demand for the 
products of other home country firms. Furthermore, the home country may lose its control over a key 
technology and with it, its position in the international market. Most public policy concern over 
outward FDI and particularly outward R&D FDI, focus on these two negative effects, disregarding the 
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international competitiveness more generally, of the home country. The foreign 
activities of MNEs may provide access to foreign technologies and, therefore, may 
represent a channel for transferring knowledge back to the home country. 
Externalities from outward FDI will occur when the MNE does not completely 
internalise all the gains derived from the investment firms (Globerman, 1994; 
Blömstrom and Kokko, 1998). First, vertical outward FDI can lead to positive 
productivity spillovers in high-tech industries if the structural shift to high value-
added activities allows the home country firms to progress along their learning curves 
and become more competitive. Second, the expansion abroad of domestic MNEs may 
increase the productivity of home-country MNE suppliers through economies of scale 
deriving from horizontal outward FDI. To the extent that these activities are 
characterised by economies of scale, the increase in foreign sales may also stimulate 
an increase in R&D expenditure by the parent company providing, in turn, a source of 
potential spillover effects for other home country. Thirdly, and more directly, positive 
externalities may derive from inter-firm RTT, i.e. from R&D activities performed 
abroad aimed at tapping into foreign centres of excellence and creating new 
technological assets that build on localised sources of knowledge. The physical 
presence in foreign markets facilitates faster and/or improved understanding of the 
new technologies being applied in those markets, since foreign affiliates have the 
opportunity to assimilate the tacit knowledge involved in the use of these innovations. 
However, Caves (1974) observes that there are other channels through which 
technology can be transferred across borders such as the international movement of 
knowledge, international trade in capital goods and lincenses. Therefore, it is 
important to stress that the role of MNE affiliates in the transfer of knowledge from 
                                                                                                                                            
potential social benefits that may derive from such investment. 
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foreign markets back to the home country will be more important in those emerging 
technology fields characterised by tacit knowledge. Indeed, tacit knowledge is one of 
the main factors explaining the localised nature of R&D spillovers and determining 
the extent to which foreign affiliates, which are close to the sources of host country 
innovations, can act as vehicles for technology transfer to other home country firms. 
There are various ways that knowledge accumulated abroad might ‘leak’ out of 
the MNE to other home country firms and institutions. The most obvious are those 
identified in the inward FDI-related spillovers literature (for a review see Blömstrom 
and Kokko, 1998), namely labour mobility, demonstration effects and backward and 
forward linkages. But there are others such as strategic alliances, licensing, informal 
sharing of know-how, and communication at conferences and fairs. For instance, as 
the result of its R&D investment abroad, an MNE may promote the adoption of a new 
production process or technology by its home country suppliers. Spillovers can occur 
as the result of a scientist or manager with work experience in a foreign affiliate, 
moving to another home country firm. And home country firms may get to know 
about and, most importantly, learn how to apply technologies developed abroad, 
through strategic alliances or other forms of co-operation with an MNE. As the 
evidence on localised knowledge spillovers (Jaffe et al., 1993) and the empirical 
literature on inward FDI shows, most of these spillover channels work best if the 
agents involved in the knowledge exchange are geographically and socially 
proximate, in other words if they are locally embedded. 
The incidence of inter-firm RTT depends on a number of factors. First, there must 
be a pool of knowledge in the host country that MNE can tap into. Thus, the greater 
the difference in the levels of technological proficiency of the host country and home 
country firms, the higher will be the potential for RTT. Second, technology sourcing 
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will be higher in the case of asset-augmenting R&D activity, and very low when R&D 
efforts are focused on the adaptation of products and processes for the local market. 
Third, and most importantly, technological knowledge should flow, voluntarily or 
involuntarily, outside the firm’s boundaries, which is dependent on the embeddedness 
of the MNE in the home country. 
Although the increasing cross-border activities of MNEs might seem to be 
rendering them ‘stateless’ corporations (Ohmae, 1990), they remain firmly rooted in 
their home countries. As Sölvell and Zander (1995) note: 
In the home base, the global firm can be characterised as an insider, where it is linked 
to other firms in both formal and informal networks … These linkages with 
geographically and culturally close actors are seen as of a certain quality and 
intensity, different from linkages that cut across national borders. They provide the 
channels for rapid dissemination of information and knowledge, and provide a basis for 
cooperation leading to continuous stream of small and large improvements. For 
example, key facilitators of information flows would include personal relationship due 
to schooling and military service, mobility of employees between competing firms, 
norms of behaviour supporting continuity and long-term relationships, or quasi-familiar 
ties between firms. (emphasis added)  
The strong embeddedness of MNEs in their home country is also reflected in the 
fact that their international operations and strategies are shaped by their home 
country’s socio-cultural and institutional legacy, as underlined by Pauly and Reich 
(1997).  
3. Method: Patenting and patent citation analysis 
Following the studies by Globerman et al. (2000) and a number of other studies 
within the international business literature (e.g. Almeida, 1996; Frost, 2001; Singh, 
2007), we track international knowledge flows using patent citations. The legal 
purpose of patent citations is to indicate which parts of the knowledge described are 
claimed in the patent and which parts are attributable to earlier patents. So, in 
principle, when a patent cites another patent, this indicates that the knowledge 
embodied in the cited patent has been useful in some way for developing the new 
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knowledge described in the citing patent, and that the citing patent has no claim over 
that particular knowledge (Jaffe et al., 1993). In other words, and for the purposes of 
this study, it is an explicit record of knowledge flows and use of received knowledge.  
However, there are some limitations to the use of patent citations to capture 
knowledge flows. First not all inventions are patented: firms can use other methofs to 
protect the returns from R&D invenstment. However, in the chemical and 
pharmaceutical sectors, studies using data from innovation surveys (see Arundel and 
Kabla, 1998) have showed that both large and small and medium sized enterprises 
(SMEs) have high patenting propensity, and thus patents are appropriate to measure 
their innovative activities. Second, patent citations are an incomplete measure of 
knowledge flows because they capture only those flows that result in a novel and 
patentable technology and, therefore, cannot be used to make inferences about tacit 
forms of knowledge, learning via imitation or reverse engineering. Consequently, in 
capturing only patent activity the results from this study provide a conservative 
estimate of RTT.  
If knowledge flows can occur without generating citations, there may also be 
citations that do not represent actual knowledge sources utilised by the inventor in the 
development of the invention. This source of noise is due to the fact that, although 
suggested by the inventor together with his/her legal adviser, the final decision about 
which patents to cite lies ultimately with the patent examiner. Recent studies have 
compared inventor and examiner citations, for both EPO (Criscuolo and Verspagen, 
2008) and USPTO (Alcacer and Gittleman, 2006) patents, and found that inventor 
citations are more localised than examiner citations, which suggests that inventor 
citations are more likely than examiner citations to indicate knowledge flows. Thus, 
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by excluding the noise introduced by examiner citations we should be able to test for 
the presence of inter-firm RTT more accurately. 
Because there can be interventions by patent attorneys and/or the inventors may be 
ignorant of a patent until after their own invention development (Jaffe et al., 1998), 
not all inventor citations capture knowledge flows. However, a recent study by 
Duguet and MacGarvie (2005) provides evidence supporting the use of EPO patents 
as a measure of knowledge flows. These authors found that citations to other patents 
were positively and significantly correlated with firm’s engagement in R&D 
collaboration, licensing of foreign technology, mergers and acquisitions and 
equipment purchases. Thus, despite their limitations in capturing real knowledge 
flows, the evidence from this study goes some way towards justifying the use of EPO 
patent citations as a reasonable proxy for knowledge flows. 
4. Data  
Our primary data source is the Organisation for Economic Cooperation and 
Development (OECD) EPO patent citation database (Webb et al., 2005) which 
contains detailed information on EPO patent applications, patent citations to other 
EPO and non-EPO patents, citations to non-patent documents, and the citation 
categories assigned by the EPO examiner in the patentability search report. Following 
Criscuolo and Verspagen’s (2008) strategy, we exploit this information to identify 
inventor citations (i.e. citations in the ‘D’ category). We assign each EPO patent to a 
European NUTS2 region and a US state, using the geographical classification of the 
inventor address in the OECD REGPAT database (Maraut et al., 2008). 
We also exploit a dataset developed by Thoma and Torrisi (2007) of EPO patent 
applications from 1,404 European publicly listed companies, which are representative 
of the most R&D-intensive sectors in Europe and account for 70% of total business 
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R&D in these European countries on average.2 In this dataset patents are assigned to 
companies, based on information on ownership links between parent companies and 
subsidiaries provided by Bureau Van Dijk’s Amadeus dataset, for 1997-2005. All 
corporate structure changes due to mergers, acquisitions and spin-offs during the 
period 1997-2005, are tracked through the Bureau Van Dijk’s Zephyr dataset.  
From the Thoma and Torrisi’s dataset we extracted EPO patent applications with 
priority years between 1985 and 2005, by the US subsidiaries of 17 of the largest 
European chemical and pharmaceutical MNEs in 2005 (see Appendix A for list of 
companies). These two sectors were selected on methodological grounds, as explained 
above, and because of the increasing internationalisation of R&D activities by MNEs 
in these industries. A number of studies (e.g. Shan and Song, 1997) show that 
European chemical and pharmaceutical MNEs exploited US knowledge to acquire the 
technological competences for many new products, especially in biotechnology. The 
US is the preferred location for asset-augmenting activities not only because of its 
technological infrastructure, but also because of the large number of small specialist 
research firms that are extremely dynamic and embedded in networks of collaborative 
relationship with universities, large firms and public and private research centres in 
the US (Gambardella et al., 2000). European MNEs are attracted to these biotech 
clusters for the benefits that can be gained from the external economies generated by 
the concentration of production and innovation activities, and for the access they give 
to high skilled workers and the research of ‘star’ academic scientists.  
4.1. Preliminary analysis of the citation data 
                                                 
2 By Europe, here we mean the 15 European Union member countries (prior to May 2004), plus Norway, 
and Switzerland. 
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We identified 18,328 EPO patent applications from the set of US subsidiaries and, 
from the OECD/EPO database, extracted 16,701 citations to this sample of patents, in 
EPO patents with priority years after 1990.3 From these citations we selected those in 
patents with at least one inventor located in a European country, which accounted for 
6,724 citations. If we exclude intra-firm citations, we have a sample of 4,805, of 
which 714 are inventor citations. Among these 4,805 citations, we identified 1,449 
home-country citations, i.e. citations made by a patent with at least one inventor 
located in the country of origin of the cited subsidiary (e.g. citations made by patents 
invented in Germany to patents granted to a US affiliate of Bayer).4 Similarly, among 
the set of 714 citations included by inventors we found 249 home-country citations.  
Using the OECD REGPAT database, we derived a similar indicator at the regional 
level. We identified the NUTS2 region in the home-country where patents owned by 
the cited MNE originate and then searched among the 4,805 citations for those citing 
patents with at least one inventor from one of the home-country regions identified. To 
take the example of Bayer, we consider a citing patent invented in Germany to be a 
home-region citation if the citing patent was invented in one of the 41 NUTS2 
German regions from which Bayer’s patents originate.  
                                                 
3 Because EPO patents do not capture to the same extent as USPTO patents (Criscuolo, 2006), US 
subsidiaries’ R&D activities, we searched in the OECD EPO database for EPO equivalents of USPTO 
and WIPO patents, i.e. EPO patents protecting the inventions with the same priority numbers as 
USPTO or WIPO patents. It is likely that US subsidiaries apply first to USPTO or WIPO before 
subsequently filing at the EPO. Thus, it is possible that an EPO citing patent refers to a USPTO or 
WIPO document rather than an EPO patent. Substituting USPTO and WIPO cited patents with their 
EPO equivalents improves our measurement of inter-firm RTT, although we cannot completely 
compensate for the fact that EPO data do not fully measure the innovative efforts of US subsidiaries.  
4 For companies such as AstraZeneca and Sanofi-Aventis, which are the result of mergers between two 
MNEs with headquarters in different countries, a citation made by a patent with at least one inventor 
located in either of the two countries of origin, to patents owned by these MNEs, is considered a home-
country citation. 
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We also identified three groups of citing firms with different international profiles:  
1) subsidiaries or headquarters of European MNEs with US operations; 
2) subsidiaries of US MNEs; 
3) domestic firms defined as firms without subsidiaries in the US, universities, 
public research institutes, government bodies and private inventors . 
For those citing firms not included in the Thoma and Torrisi’s dataset, we checked 
the names of the assignees manually, using several sources (LexisNexis Corporate 
Affiliations directory, Bureau Van Dijk’s Zephyr database, and company websites) in 
order to assign the citing firm to one of the above three categories. This was done to 
control for the fact that MNEs might have acquired the knowledge developed in the 
US either directly through their presence in the US or indirectly through their 
organisational networks. Domestic firms and institutions would most probably be 
reliant on their linkages with relevant MNEs to access technological knowledge 
accumulated in the US. It is for this group of organisations that MNEs may be an 
important channel for international transfer of knowledge. Figure 1 shows the 
alternative technology transfer channels for firms with US operations to access 
knowledge developed there.  
********* INSERT FIGURE 1 ************ 
Table 1 reports the breakdown of home-country and home-region citations across 
the three groups of firms. A large proportion of citations are contained in patents 
applied for by European MNEs, but almost 30% of all citations originate from 
domestic firms or institutions and 30% of these are in patents whose inventors are 
located in the home country of the cited subsidiary. When we examine the sub-sample 
of citations included by the inventor, on average, the share of home-country citations 
is higher than in the entire sample (35% vs 30%). This appears to be driven by the 
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greater proportion of home-country citations among European MNEs and domestic 
firms. Conversely, there are fewer home-region inventor citations in the sample of 
inventor citations than in the entire sample and particularly in the case of European 
MNEs.  
These figures suggest that citation patterns differ across these three groups of 
firms and depend on whether the home region or the home country is used as the 
geographical unit of analysis. They also show that both multinational companies in 
the home-country of the cited subsidiary and domestic firms appear to benefit from 
this RTT process, but this needs to be statistically tested. We use two methods to test 
for whether a US subsidiary facilitates the diffusion of knowledge to other home-
country firms: the matching method, which tests whether the frequency of home-
country and home-region citations is higher than a reference baseline probability, and 
a citation-level multivariate regression analysis, which enables us to directly control 
for other determinants of the citation pattern. 
5. Testing for the presence of inter-firm RTT 
5.1. The matching method 
This method builds on the approach originally proposed by Jaffe, Trajtenberg and 
Henderson (1993) and subsequently applied by Almeida (1996) in the context of 
knowledge flows among foreign subsidiaries and domestic firms. Figure 2 shows that 
the approach consists of constructing a set of citing patents invented in Europe, each 
citing at least one of the originating patents.  
/******* INSERT FIGURE 2 AROUND HERE **********/ 
To test for the presence of inter-firm RTT we need to examine how many of 
these citing patents are invented in the home-country of the cited MNE. To be able to 
infer that the observed frequency of home-country match is greater than would be 
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expected given the existing geographical distribution of R&D activities in the relevant 
technical field and time period, we match each citing patent to a control patent with 
the same priority year and the same 4-digit International Patent Class (IPC) which 
does not cite the originating patent. We compare the frequency of home-country 
matching between control patent and corresponding cited patent with that in the 
sample of citing patents.  
To test whether there is a statically significant difference between the two 
proportions of home-country citations we use a t statistic to test for the difference 
between two independently drawn binomial proportions, which is derived as follows:  
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where p0 and pc are the proportions of home-country citations in the sample of citing 
patents and control patents, respectively, and no and nc are the number of citations in 
the two samples. A positive and significant t-statistic value indicates that home-
country citations are higher than would be expected among a sample of citing patents 
invented in Europe with similar temporal and technology profiles.  
Table 2 reports the results of the matching procedure at country and regional 
levels, and using one and four matched control patents. Across all samples the t-
statistic is significant at the 0.01 level, which indicates that there is a higher 
proportion of home-country and home-region citations in both the entire sample and 
the sub-sample of inventor citations, than in the control sample. 
These findings suggest that home-country firms benefit from the R&D 
activities conducted in the US by domestic MNEs, and these benefits are particularly 
stronger for home-country firms located in the same region as the national 
subsidiaries of the investing MNE. Indeed, the difference between pc and po is higher 
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at regional than at country level for both the entire sample and the sample of inventor 
citations. This indicates that some of the mechanisms through which knowledge is 
transferred from the investing MNE to other home-country firms, such as labour 
mobility, informal know-how sharing, or demonstration effects, operate at the 
regional level as suggested by the literature on localised knowledge spillovers (Jaffe 
et al., 1993). 
5.2 Citation-level regression analysis 
To test the robustness of the results from the matching method we carried out 
a citation-level multivariate regression analysis following the approach proposed by 
Singh (2007). This method allows us to directly control for alternative explanations of 
the observed citation patterns such as the technological characteristics of the cited 
patent, the technological specialisation of the citing firm’s country and, most 
importantly, the citing firm’s international profile. This method consists of estimating 
the probability of citation between two patents extracted from a pool of potentially 
citing and cited patents. In our study the number of potentially cited patents 
corresponds to the entire US subsidiaries sample’s patents, regardless of whether or 
not they have been cited by a European inventor.  
The sample of potentially citing patents is more difficult to define since, in 
theory, it should be equal to all patents invented in Europe. However, identifying the 
international profiles of all the applicants of EPO patents invented in Europe would 
require manually checking for the names of the assignees in different databases to 
identify the home countries of the ultimate owners and to establish whether the citing 
firm had a subsidiary in the US. Here, the set of potentially citing patents is all those 
patents owned by the sample of 1,404 European firms in the Thomas and Torrisi’s 
dataset whether or not they cite patents in our US subsidiaries sample. Since this 
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dataset excludes private inventors, universities, European subsidiaries of US MNEs, 
and small European SMEs we added all patents owned by these applicants that cite 
the set of originating patents. 
Having defined the set of potentially citing patents - 310,690, and cited patents -
18,328, we identified all potentially citing-cited pairs, in other words, we created a 
dataset with millions of observations in which the number of actual citations is 
extremely small. In this case estimating the probability of citation using a traditional 
logit model would significantly underestimate the probability of a positive outcome 
(King and Zeng, 2001).  
We apply a choice-based sampling procedure, which includes all actual citations 
(y = 1) and randomly extracts a set of matched control patent pairs that do not cite 
each other (y = 0). The matching procedure adopted the following criteria: the control 
patent pair belongs to the same 4-digit IPC as those in the original citation pair; the 
control citing patent was applied for after the original cited patent; the control cited 
patent was applied for in the same year as the original cited patent; the patents in the 
control pair are not owned by the same MNE. King and Zeng (2001) recommend 
between two to five non-occurring events for every occurring event. We include 4 
control citations for each observed citation. This resulted in a dataset containing 
24,024 citation pairs of which 4,805 are actual citations and 19,219 are control 
citations. A similar procedure was used to derive a dataset with 3,566 citing-cited 
pairs added by the inventor, which included only the 714 actual citations.  
The use of choice-based sampling introduces bias in the estimated model, which 
can be corrected using a weighted exogenous sampling maximum-likelihood 
estimator (WESMLE) (King and Zeng, 2001). Tomz’s (2001) Stata procedure was 
used to estimate this so-called rare event logit model.  
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Since both citing and cited patents can have more than one inventor, and these 
inventors might be located in different countries and regions, we consider all possible 
combinations between the citing and cited locations (countries or regions) and assign 
to each observation a given weight. Let us assume that a citing patent has inventors 
from m different countries and the cited patent has inventors from n different 
countries, we then have m*n combinations of citing and cited countries, which implies 
a weight equal to 1/m*n should be assigned to each observation. The rare event logit 
model is estimated using these weights as importance weights. Finally, to address the 
fact that the same citing patent appears in the dataset more than once, we report robust 
errors clustered on citing patent.  
5.2.1 Specification of the model 
We estimate a rare event logit model using the following specification:  
dummies MNE cited
dummiescountry  citing765
43210
++++
+++++=
AveragecitCitePubCMultipleIP
SametechTechnCompTYPEHomectryy
ii
ijjjjij
βββ
βββββ
 
where the dependent variable y is a binary variable equal to 1 if patent j cites patent i 
applied for by our sampled US subsidiary.  
To test for the presence of inter-firm RTT we need to examine whether home 
country firms show a learning advantage over firms located in other European 
countries. Therefore, we include a dummy variable (Homectry) that takes the value 1 
if the citing patent originates from the home country of the cited subsidiary and 0 
otherwise. An odds ratio greater than 1 and statistically significant would indicate that 
firms located in the home country of the cited MNE are more likely than other 
European firms to cite US subsidiaries’ patents and thus would point to evidence of 
inter-firm RTT.  
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To control for other channels of technology transfer, we included a set of 
dummy variables (TYPE) that identify the three groups of citing firms located in 
Europe - subsidiaries of MNEs (MNE), subsidiaries of European multinationals 
(EUMNE), subsidiaries of US multinationals (USMNE) - and the reference category 
domestic firms and institutions (DomesticFirm). If the Homectry variable is still 
significant after controlling for the international profile of the citing firm this would 
support the existence of inter-firm RTT in addition to other potential mechanisms for 
international technology transfer.  
The probability of citation will also be a function of the degree of 
technological specialization of the country in which the citing firm is located. To 
account for this, we include a variable (TechCom), which is the share of patents 
originating from the citing inventor’s country in the same technology class of the 
cited patent and in the same priority year of the citing patent.5 This variable is crucial 
for identifying RTT since, if the odds ratio of Homectry remains significant and 
greater than 1 when TechComp is included, then we can be sure that this effect exists 
over and above any technological capabilities inherent in the home country.  
Because citations are more likely to occur between patents in similar 
technological domains, we include a dummy variable (Sametech) which is equal to 1 
if the citing and cited patents belong to the same primary 7-digit IPC of technology. 
Similarly, there is evidence that the number of forward citations is positively related 
to the number of patent classes appearing in a patent (Fleming and Sorenson, 2004), 
because a patent classified in multiple technology classes is more likely to appear in 
                                                 
5 We classify patents in 30 broad technology fields using the classification scheme provided by the 
Observatoire des Sciences et des Techniques (OST) and the Fraunhofer Institute (FhG-ISI) (see OST, 
2002 appendix A5a-1 p. 346). 
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the searches of other inventors and/or in examiners. We, therefore, include a dummy 
variable (MultipleIPC) which equals 1 if the cited patent has been classified in more 
than one IPC. Forward citations are also more likely to occur when patents build on 
basic research, since these have a greater impact than those patents that do not cite 
scientific publications (Fleming and Sorenson, 2004). We therefore include a dummy 
variable (CitePub) which equals 1 if the cited patent contains citations to non-patent 
documents and 0 otherwise.  
To correct for truncation or ‘cohort’ effects (i.e. patents granted in 1985 may 
receive more citations than patents granted in 2000) and for unobserved differences in 
citations across technology fields we include a variable for the average number of 
citations received by EPO patents applied for in the same year and in the same 
technology class of the cited patent (Averagecit). Finally we include a series of 
country dummies for citing patent countries and a series of cited MNE dummies to 
account for unobserved country and cited firm fixed effects. To improve the 
readability of the tables, we have not included the coefficients for these control 
variables.  
5.2.2. Results of the econometric analysis 
The results of the regression analyses at the country level are presented in Table 3, 
which reports the odds ratios for both the estimates obtained using the entire sample 
of citations (Columns 1-5) and those for the sub-sample of inventor citations 
(Columns 6-10).  
The estimates in Column 1 provide support for the presence of inter-firm RTT: the 
odds ratio of the Homectry variable is greater than 1 and statistically significant. In 
particular, firms located in the home country of the cited MNE are 23% more likely 
than other European firms to cite patents owned by the US subsidiaries of these 
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MNEs. The Homectry dummy is still significant when we control for the inherent 
technological capability of the country of the citing firm (TechComp) (see estimates in 
Column 2). This variable has a significant and positive impact on the probability of 
citation, which supports the idea that absorptive capacity is crucial in the technology 
transfer process.  
*************** INSERT TABLE 3 HERE ********** 
The models in Columns 3 and 4 control for whether the citing firm has a 
subsidiary in the US. As Figure 1 showed, it is possible that firms with US operations 
might gain access to technologies developed in the US through their organisational 
networks and, thus, that the flow of knowledge, from the US subsidiary to the home 
country firm, does not go through the subsidiary’s headquarters, in other words it is 
not true RTT. In Column 3 we include a variable capturing whether the citing firm is 
a MNE active in the US, and in Column 4 we distinguish between the subsidiaries of 
US and European MNEs to check whether firm nationality makes a difference. 
The fact that the Homectry variable is still significant and positive in these two 
regressions reinforces the findings related to the positive role of MNEs in cross-
border technology transfer. Of interest, is that European or American MNEs are 53% 
and 18% less likely to cite US subsidiaries patents than European domestic firms and 
institutions, respectively. This suggests that multinational companies in Europe are 
able to monitor developments in the US through their networks of subsidiaries.  
To test for whether domestic companies in the home country of the cited MNE 
show a learning advantage relative to other domestic firms located in other European 
countries, we re-ran the model for the sample of citing firms without US operations.6 
                                                 
6 This dataset was derived following the procedure described in the previous section, but using as the 
set of potentially citing patents, all those patents applied for by European domestic firms and 
institutions. 
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For this sample of firms we can rule out the presence of channels of international 
technology transfer other than exports, and assume that MNEs might represent an 
important conduit for foreign developed technologies. Estimates reported in Column 5 
show that the coefficient on the Homectry dummy is positive and significant.  
When we examine the sub-sample of citations added by the inventor (see 
Columns 6-10) the results are similar. In particular, for this sample of citations, which 
more directly tracks knowledge flows, we find odds ratios for the Homectry variable 
of the order of 1.35 (1.85), meaning that (domestic) firms in the home country of the 
cited MNE are 35% (85%) more likely than (domestic) firms located in other 
European countries to cite a US subsidiary’s patent. This seems to confirm the 
presence of inter-firm RTT. The MultipleIPC dummy is never significant in these 
models, which suggests that inventors are less likely than examiners to carry out 
complex patent searches. 
Finally, we estimate a set of models using regions instead of countries as 
geographical unit of analysis. The Homeregion dummy variable is equal to 1 if the 
citing patent has at least one inventor located in one of the NUTS2 regions from 
where patents owned by the cited MNE originate. The TechComp variable is also 
defined at the regional level: it is equal to the share of patents invented in the citing 
inventor’s region in the same technology class as the cited patent, and in the same 
priority year of the citing patent. Results of these estimations are reported in Table 4: 
Columns 6-10 show the estimates obtained using the sub-sample of inventor citations.  
The main findings at country level mostly hold at regional level. The most 
important exception is the lack of significance of the Homeregion dummy when we 
consider the sample of inventor citations by domestic firms and institutions (Column 
10), which could indicate that what matters for these small domestic firms is not so 
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much proximity to a cited MNE’s unit, but location in the home country of the MNE. 
This finding is line with Dickens et al.’s (1994) argument that when the concept of 
local embeddedness is applied to MNEs, ‘local’ should be interpreted as ‘national’ 
and not a small within country geographic area. As in Table 3, what seems to 
determine the likelihood of citation among the sample of inventors from domestic 
firms and institutions is the technological similarity between the citing and cited 
patents.  
******** INSERT TABLE 4 HERE ************* 
6. Exploring the determinants of inter-firm RTT 
The analyses so far have examined whether MNEs act as a channel for the 
transmission of knowledge developed abroad to other home country firms, but have 
not investigated what determines inter-firm RTT. We have argued that this 
phenomenon might arise from asset-augmenting R&D units. We have also assumed 
the existence of a technological gap between the host and the home locations, for this 
process to take place, and that knowledge that originated in the US is channelled 
through the parent company to other home-country firms based on their high 
embeddedness in the home country.  
We now examine whether the above factors explain the occurrence of inter-firm 
RTT by estimating a rare event logit model, where the dependent variable (y) is equal 
to 1 if there is a citation between a patent applied for by a US subsidiary and a patent 
invented in the home country of the cited MNE or from one of the regions where the 
cited MNE patents originate, and 0 otherwise.7 
                                                 
7 The datasets we use to estimate these models were derived using the approach described in Section 
5.2 where the set of potentially citing patents is all EPO applications by inventors located in the home 
country of the cited MNE. 
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The first three explanatory variables try to capture the degree of home country 
embeddedness of the cited MNE’s manufacturing operations and core value adding 
activities. ShareHomectryEmpl is equal to the average percentage of employees in the 
home country over the period 1990 and 2005, using information extracted from 
companies’ financial reports and from UNCTAD World Investment reports. MNEs 
with a large proportion of their manufacturing and non manufacturing activities in the 
home country will have strong linkages with local suppliers, trade unions, national 
and regional governments, and trade associations. ShareHomectryPats is the number 
of patents originating from the home-country over total patents applied for by the 
cited MNE. ShareHomectryCoPats is derived as the number of joint patent 
applications with other home country firms or institutions over total number of joint 
applications. Both these indicators measure the level of concentration of upstream 
activities in research, development and engineering in the home country and, 
therefore, capture the extent of linkages with home country universities, research 
institutes, consumers, suppliers and competitors. Although these three variables do 
not directly measure these linkages they do however provide a good proxy for their 
presence and strength. 
 The role of the MNE as conduit of the knowledge developed in the US 
subsidiaries is captured by a dummy variable that is equal to 1 if the cited patent has 
been cited by other units of the same MNE (Selfcitation). Although there are other 
ways in which MNEs can exploit the knowledge produced by US subsidiaries, which 
are not reflected in patent citations, self-citation has been used in previous studies to 
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measure intra-firm RTT (Singh, 2007). The technological gap between the home and 
host location is measured by the ratio of the number of patents in the same 3-digit IPC 
of technology of the cited patent originating from the country in which the citing firm 
is located, over those invented in the US in same priority year as the cited patent 
(TechGap).  
The asset-augmenting nature of the R&D activities carried out by the US 
subsidiaries is measured by three variables: CitePub and PatFam characterising the 
cited patent, and Sophi characterising the technological leadership of the US 
subsidiary. CitePub captures the basic nature of the knowledge contained in the cited 
patent; PatFam measures the economic value of the cited patent by counting the 
number of patent offices where the patent is protected. Because applying for patent 
protection in more than one patent office is expensive, we would expect that patents 
that are protected in multiple offices will be economically more valuable, i.e. to have 
expected returns high enough to outweigh the costs of filing in more than one foreign 
patent office (Putnam, 1996). Asset-augmenting R&D activities tend to produce less 
context-specific and more basic knowledge, thus we would expect US subsidiaries 
engaged in this type of innovative activities to apply for patents which build on, and 
thus reference, scientific research and which have applicability in other countries, thus 
with greater economic value and, consequently, larger patent families. Sophi measures 
the distance of the cited subsidiary’s innovative activity from the technological 
frontier. It is equal to the average across the 634 4-digit IPC, of the ratio of the 
forward citations received by the cited subsidiary’s patents to the number of forward 
citations received by the average patent in that class (MacGarvie, 2006): 

=
=
N
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where Nit is the number of technology classes in which the cited subsidiary has 
patented in year t, intc is the average number of forward citations received by patents 
applied for by subsidiary i in year t in class n, and ntc is the average number of 
forward citations received by patents in class n in year t. This variable captures the 
importance and value of patents applied for by the US subsidiary relative to the 
overall average, correcting for the differences in citation frequencies across 
technological classes. A value of Sophi greater than 1 suggests that the subsidiary is a 
technology leader; a value less than 1 suggests the firm is a technology follower.  
As in previous models, we include a variable measuring the technological 
similarity between the citing and cited patent defined at the 7-digit IPC (SameTech), 
the average number of citations received by EPO patents applied for in the same year 
and in the same technology class of the cited patent (Averagecit), citing inventor 
country and cited MNE dummies.  
Table 5 compares the means and standard deviations of the main explanatory 
variables, across the sample of home country (inventor) citations and control 
(inventor) citations, highlighting several significant aspects. First, on average the level 
of embeddedness of the cited MNE is higher among the sample of home country 
citations. Second, US invented patents cited by home country firms on average are 
more likely to be also cited by other units of the MNEs that own them; they are also 
more likely to include references to scientific publications and to be protected in more 
patent offices. Third, foreign subsidiaries cited by home country firms seem to be 
fairly heavily involved in cutting-edge research: on average the Sophi variable is 
greater than 1 for the sample of home country citations and higher than the 
corresponding average for the control citations.  
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*************** INSERT TABLE 5 HERE ********** 
6.1 Results of the econometric analysis 
Table 6 reports the odds ratios for the rare event logit models estimated at country and 
region level, for the entire sample of citations and for the sample of inventor citations. 
Across all models the technological leadership of the cited subsidiary has a positive 
and significant effect on the likelihood of a home country or home region citation. 
Based on the estimates in Column 1, we find that for one standard deviation increase 
in the Sophi variable and holding all the other variables constant, the odds for home 
country citation are 1.37 times higher. Also, the other two variables capturing the 
asset-augmenting nature of the R&D activities of US subsidiaries (CitedPub and 
PatFam) appear to have a positive and mostly significant effect on the likelihood of a 
home country or home region citation.  
*************** INSERT TABLE 6 HERE ********** 
The extent of home country embeddedness also appears to positively and 
significantly affect the likelihood of home country citation. The proportion of joint 
co-patenting activity with other home country firms and institutions is consistently 
significant and positive across all the models as is, in most models, the share of 
employment in the home part of the MNE. The proportion of patents originating from 
the home country of the cited MNE, although positive, does not always reach 
significance. The pattern is similar for the Selfcitation dummy which, although 
positive, is never significant for the sample of inventor citations, which might be due 
to the smaller sample size. When TechGap is significant the odds ratio is less than 1, 
which implies that inter-firm RTT is more likely to occur when the technological 
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capability of the US or the host US state, is stronger than that of home country or 
home region.  
7. Conclusion 
This study tested for the existence of an inter-firm RTT process, i.e. a technological 
knowledge flow from a MNE’s foreign based R&D facilities to its home country 
firms. The findings show that these reverse knowledge flows exist even after 
controlling for a number of other potential explanations for the observed citation 
pattern. We also found that the degree of home country embeddedness, the 
engagement in asset-augmenting R&D activities by the US subsidiaries, and the 
existence of a technological gap between the host and home countries determine the 
occurrence of inter-firm RTT.  
Our results provide an alternative view of R&D FDI. The relocation of R&D 
activities abroad might not necessarily entail an erosion of national technological 
competitiveness. Also, it may improve the overall innovative performance of the 
investing firm and of other home-country firms through reverse transfer of 
technological assets developed in the foreign locations. National governments have 
tended to encourage MNEs to maintain their R&D activities at home, by limiting 
subsidies to R&D performed at home, for example, not favouring the re-location of 
this investment to foreign countries, and ignoring the possibility of RTT. If there were 
major formal or informal barriers to overseas R&D, it is possible that both the 
investing firm and other home-country players could be excluded from important 
product and process developments, which could lead to competitive disadvantage.  
Particularly in R&D-intensive and technologically complex industries, innovation 
sources have become much more dispersed and, in order to remain internationally 
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competitive, firms require access to foreign technological developments. Thus, it 
would be detrimental to an economy if its major companies were not able to 
undertake R&D activities abroad, given the high degree of specialisation in the 
generation of technological knowledge and the growing importance of critical pockets 
of excellence abroad. Indeed, it could be argued that firms should be encouraged to 
undertake foreign R&D investments so that other domestic firms can gain access to 
new technologies and knowledge.  
However, to reap the greatest home country benefits from R&D performed abroad, 
policy makers should ensure that the multinational’s R&D function is well embedded 
in the home country. On the one hand this could be achieved by strengthening the ties 
between home-country firms and institutions and the multinational firms undertaking 
R&D investment abroad through enhanced inter-firm cooperation and inter-firm 
mobility of highly qualified workers. On the other hand this goal could be achieved 
by maintaining and enhancing the attraction of the home country as a location for 
undertaking R&D activities. To increase the attractiveness of a country as a location 
for R&D policy makers could foster scientific excellence through the creation of both 
scientific and technological networks of public and private research. Such policies 
would also achieve the objective of attracting foreign R&D investments aiming at the 
creation of forefront technology.  
To what extent a passive internationalisation strategy, i.e. one encouraging R&D 
investment from foreign firms, is better than a ‘active’ one, i.e. encouraging R&D 
investment abroad, will be country and sector specific. As pointed out by Van 
Pottelsberghe de la Potterie and Lichtenberg (2001) the trade-off between these two 
strategies is like choosing what is the best way to learn a foreign language: talking 
with foreigners living in one’s home country or choosing to live in a foreign country. 
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The latter seems more appropriate if one considers also the fact that the former 
strategy has the problem that, to a great extent, foreign companies cannot be chosen, 
and in particular it is very difficult to select the amount and the quality of technology 
they are willing to transfer. In addition foreign companies might displace domestic 
R&D by competing for limited specialised resources, such as highly-skilled workers. 
However the ‘active’ internationalisation strategy has other drawbacks. A policy that 
subsidises the relocation of R&D activity abroad needs to assess to what extent the 
technological knowledge acquired abroad is completely internalised by the investing 
firm or spills over to other domestic firms, generating positive externalities for the 
domestic economy. Another cost of this internationalisation strategy may arise if 
MNEs stop interacting with the domestic innovation system and instead turn 
exclusively to co-operation with foreign partners. Therefore it is important to stress 
that a policy aiming to encourage R&D investment abroad should be coupled with a 
policy aiming to capture greater local benefits from these investments.  
Our analysis provides reasonable, but not conclusive, evidence of RTT. Although 
useful, patent citation analysis has some limitations, the most serious being the use of 
patent citations as a proxy for knowledge flows: citations are not only included by 
inventors, they can be added by patent examiners. To overcome this limitation we 
excluded examiner citations from our estimations, and used only the sample of 
inventor citations, which are more likely to represent a knowledge spillover. Although 
we were able to test the robustness of our findings by eliminating the noise introduced 
by examiner citations, we were not able to identify the channels and mechanisms 
enabling RTT. Information on the channels and mechanisms enabling RTT would be 
extremely useful for formulating managerial and policy prescriptions and future work 
in this area would be beneficial. This research could include analysis of how a 
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particular product or process innovation by a foreign subsidiary abroad, diffuses 
within the MNE’s home country and could focus on the mechanisms through which 
knowledge developed abroad diffuses to other home country firms, e.g. R&D 
collaborations, licensing agreements, strategic alliances, or inter-firm labour mobility.  
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 Table 1 Descriptive statistics of citations made by patents invented in Europe to US 
subsidiaries’ patents (excluding intra-firm citations)  
Citing firms 
Entire sample Inventor citations 
# of 
citations 
% Total 
citations 
% Home-
country 
citations 
% Home-
region 
citations 
# of 
citations 
% Total 
citations 
% Home-
country 
citations 
% Home-
region 
citations 
Units of US MNEs 698 14.7 35.1 34.8 77 10.8 24.7 25.0 
Units of EU MNEs 2,681 56.4 30.2 27.7 503 70.9 36.6 19.7 
Domestic firms 1,372 28.9 28.0 26.2 129 18.2 35.7 28.3 
Overall  4751 100 30.3 28.3 709 100 35.1 24.2 
 
Table 2 Testing for RTT: matching method results 
Country level analysis 
 Entire sample Inventor citations 
 
Citing 
Patents 
1 match 4 matches 
Citing 
Patents 
1 match 4 matches 
 
Control 
Patents 
Control 
Patents 
Control 
Patents 
Control 
Patents 
Number of citations 4,805 4,732 18,409 714 650 2,267 
Proportion of home-country 
citations 
30.15 27.36 27.53 34.87 29.1 29.33 
t-statistics 3.01 3.551 2.299 2.737 
Regional level analysis 
 Entire sample Inventor citations 
   1 match 4 matches   1 match 4 matches 
 
Citing 
Patents 
Control 
patents 
Control 
Patents 
Citing 
Patents 
Control 
Patents 
Control 
Patents 
Number of citations 4,790 4,685 17,987 713 640 2,135 
Proportion of home-region 
citations 
33.46 28.6 29.3 39.87 30.62 33.4 
t-statistics 5.124 5.463 3.561 3.067 
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Table 3 Testing for the presence of inter-firm RTT: rare event logistic regressions, country level analysis  
  
Entire Sample Inventor Citations 
1 2 3 4 5^ 6 7 8 9 10^ 
SameTech 3.399*** 3.425*** 3.352*** 3.173*** 2.980*** 5.005*** 5.255*** 5.244*** 5.052*** 7.469*** 
 (0.135) (0.138) (0.137) (0.133) (0.206) (0.572) (0.614) (0.616) (0.597) (2.705) 
MultipleIPC 1.251*** 1.253*** 1.236*** 1.272*** 1.396*** 0.976 0.952 0.978 0.992 1.189 
 (0.056) (0.056) (0.056) (0.058) (0.116) (0.122) (0.119) (0.124) (0.125) (0.400) 
CitePub 1.343*** 1.348*** 1.306*** 1.330*** 1.406*** 1.537*** 1.539*** 1.551*** 1.572*** 0.989 
 (0.058) (0.058) (0.058) (0.059) (0.105) (0.193) (0.193) (0.194) (0.198) (0.311) 
Averagecit 1.514*** 1.516*** 1.534*** 1.504*** 1.409*** 1.758*** 1.768*** 1.759*** 1.740*** 2.696*** 
 (0.046) (0.046) (0.047) (0.047) (0.070) (0.159) (0.162) (0.161) (0.159) (0.702) 
Homectry 1.230*** 1.232*** 1.217*** 1.177*** 1.177* 1.337* 1.324* 1.363** 1.367** 1.850** 
 (0.067) (0.067) (0.068) (0.066) (0.103) (0.203) (0.201) (0.210) (0.212) (0.580) 
TechComp  1.019** 1.026*** 1.026*** 1.026*  1.074*** 1.076*** 1.063** 1.041 
  (0.009) (0.009) (0.009) (0.015)  (0.029) (0.029) (0.029) (0.068) 
MNE   0.451***     0.658***   
   (0.020)     (0.093)   
EUMNE    0.412***     0.617***  
    (0.019)     (0.088)  
USMNE    0.819***     1.116  
    (0.060)     (0.252)  
Observations 30703 30703 30703 30703 8985 4661 4661 4661 4661 826 
Log-likelihood -14278.2 -14274.5 -14065.4 -13972.4 -4146.62 -2082.59 -2075.39 -2067.99 -2064.41 -345.523 
χ2 2425.745*** 2433.21*** 2851.449*** 3037.292*** 623.627*** 650.16*** 664.569*** 679.372*** 686.537*** 172.469*** 
Count R2± 0.797 0.797 0.799 0.800 0.804 0.801 0.802 0.804 0.802 0.812 
Adj Count R2±± -0.002 0.001 0.001 0.013 0.006 0.062 0.068 0.076 0.066 0.134 
Robust standard errors clustered on citing patent in brackets. Citing country and cited MNE dummy variables included 
^  Model 5 and 10 use as a set of potentially citing patents those applied for by domestic firms and institutions 
± Proportion of correct predictions ±± Improvement in correct predictions beyond what would have been achieved by simply predicting the most common outcome 
*** p<0.01, ** p<0.05, * p<0.1 
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Table 4 Testing for the presence of inter-firm RTT: rare event logistic regressions, regional level analysis  
  
Entire sample Inventor citations 
1 2 3 4 5^ 6 7 8 9 10^ 
SameTech 3.372*** 3.391*** 3.307*** 3.131*** 2.905*** 5.231*** 5.189*** 5.174*** 5.024*** 8.077*** 
 (0.139) (0.140) (0.140) (0.135) (0.207) (0.638) (0.639) (0.642) (0.627) (3.104) 
MultipleIPC 1.230*** 1.226*** 1.213*** 1.244*** 1.362*** 0.955 0.947 0.973 1 1.374 
 (0.057) (0.056) (0.057) (0.059) (0.116) (0.127) (0.126) (0.131) (0.134) (0.490) 
CitePub 1.334*** 1.327*** 1.295*** 1.315*** 1.458*** 1.464*** 1.449*** 1.466*** 1.488*** 0.727 
 (0.060) (0.060) (0.060) (0.061) (0.113) (0.197) (0.196) (0.197) (0.201) (0.236) 
Averagecit 1.530*** 1.536*** 1.548*** 1.520*** 1.409*** 1.867*** 1.835*** 1.820*** 1.827*** 3.281*** 
 (0.049) (0.049) (0.050) (0.049) (0.072) (0.185) (0.183) (0.182) (0.182) (0.910) 
Homeregion 1.306*** 1.295*** 1.287*** 1.228*** 1.232** 1.512*** 1.540*** 1.566*** 1.550*** 1.329 
 (0.073) (0.073) (0.073) (0.071) (0.111) (0.229) (0.233) (0.239) (0.238) (0.472) 
TechComp  0.994** 0.999 0.995** 0.99  1.01 1.012 1.006 1 
  (0.003) (0.003) (0.003) (0.008)  (0.008) (0.008) (0.008) (0.031) 
MNE   0.449***     0.676***   
   (0.021)     (0.101)   
EUMNE    0.411***     0.624***  
    (0.019)     (0.093)  
USMNE    0.836**     1.326  
    (0.064)     (0.316)  
Observations 43693 43693 43693 43693 13041 6735 6735 6735 6735 1125 
Log-likelihood -19822.8 -19816.5 -19498.9 -19365.7 -5895.12 -2817.13 -2811.02 -2805.91 -2795.47 -454.796 
χ2 3551.695*** 3564.39*** 4199.543*** 4465.997*** 1032.934*** 1172.175*** 1184.385*** 1194.602*** 1215.489*** 238.142*** 
Count R2 0.804 0.803 0.806 0.808 0.808 0.814 0.818 0.818 0.815 0.823 
Adj Count R2 -0.002 -0.008 0.009 0.019 0.008 0.088 0.104 0.106 0.092 0.146 
Robust standard errors clustered on citing patent in brackets. Citing country and cited MNE dummy variables included. 
^  Model 5 and 10 use as a set of potentially citing patents those applied for by domestic firms and institutions 
*** p<0.01, ** p<0.05, * p<0.1 
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Table 5 Descriptive statistics 
Variables 
Home country citations 
No (N=6837) Yes (N=1921) 
Mean St.Dev Mean St.Dev 
ShareHomectryEmpl 43.71 13.60 46.78 12.69 
ShareHomectryCoPat 22.19 17.35 25.28 16.95 
ShareHomectryPats 45.62 17.29 48.64 15.33 
Selfcitation 0.20 0.40 0.33 0.47 
TechGap 1.37 0.95 1.32 0.70 
Sophi 1.09 0.32 1.17 0.35 
CitePub 0.20 0.40 0.31 0.46 
PatFam 6.25 4.71 7.91 6.00 
Sametech 0.20 0.40 0.46 0.50 
  
Home country inventor citations 
No (N=1279) Yes (N=405) 
ShareHomectryEmpl 42.39 13.48 45.86 12.02 
ShareHomectryCoPat 20.35 16.91 25.68 17.21 
ShareHomectryPats 45.20 16.81 48.28 14.98 
Selfcitation 0.19 0.39 0.26 0.44 
TechGap 1.36 0.91 1.35 0.86 
Sophi 1.12 0.35 1.17 0.37 
CitePub 0.26 0.44 0.34 0.48 
PatFam 6.71 5.09 10.57 7.42 
Sametech 0.16 0.36 0.48 0.50 
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Table 6 Identifying the determinants of inter-firm RTT: rare event logistic regression  
 
Country-Level Regional Level 
Entire 
Sample 
Inventor 
Citations 
Entire 
Sample 
Inventor 
Citations 
1 2 3 4 
ShareHomectryEmpl 1.057*** 1.043* 1.051*** 1.037 
 (0.013) (0.025) (0.013) (0.028) 
ShareHomectryCoPat 1.048*** 1.069*** 1.047*** 1.068*** 
 (0.006) (0.012) (0.006) (0.013) 
ShareHomectryPats 1.002 1.039*** 1.008* 1.042*** 
 (0.005) (0.016) (0.005) (0.017) 
Selfcitation 1.505*** 1.177 1.573*** 1.232 
 (0.124) (0.268) (0.132) (0.294) 
TechGap 0.770*** 1.081 0.975* 1.014 
 (0.050) (0.150) (0.014) (0.033) 
Sophi 2.578*** 2.544** 2.454*** 2.381** 
 (0.381) (0.991) (0.363) (0.885) 
CitePub 1.797*** 1.529 1.788*** 1.467 
 (0.172) (0.428) (0.175) (0.445) 
PatFam 1.047*** 1.093*** 1.045*** 1.079*** 
 (0.009) (0.024) (0.009) (0.025) 
Sametech 4.044*** 6.793*** 3.931*** 7.678*** 
 (0.339) (1.724) (0.335) (1.985) 
Averagecit 1.220*** 1.196 1.123* 1.185 
 (0.083) (0.215) (0.076) (0.224) 
Observations 8744 1644 13281 2498 
Log-likelihood -4021.26 -725.969 -6004.38 -988.102 
χ2 1165.268*** 381.48*** 1732.506*** 595.281*** 
Count R2 0.798 0.790 0.803 0.826 
Adj Count R2 0.083 0.146 0.072 0.173 
Robust standard errors clustered on citing patent in brackets. Citing country and cited MNE dummy variables included. 
*** p<0.01, ** p<0.05, * p<0.1     
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Figure 1 Reverse technology transfer process 
 
Reverse technology transfer  Other technology transfer channels
HQb 
Suba 
HQc 
Subb HQa 
Subc 
SME 
 
Company a is one of the chemical and pharmaceutical MNEs in our sample; company b a 
European MNE; company c a US MNE; and SME a domestic firm 
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Figure 2 Research Design of the Matching Procedure 
 
 
ORIGINATING PATENTS 
(EPO applications by US 
subsidiaries of European 
MNEs) e.g. Applications by 
Bayer’s US subsidiary 
CITING PATENTS 
(EPO applications by 
inventors located in 
Europe) e.g. BP UK 
citing Bayer’s US 
subsidiary patents 
CONTROL PATENTS 
(EPO applications by inventors 
located in Europe matched by 
priority date and technology class 
to the citing patents but that do 
not cite the original patent)  
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Appendix 
Table A1 List of companies in the sample 
Company name 
Country 
of origin 
AKZO NOBEL  NL 
ASTRAZENECA  UK/SE 
BASF  DE 
BAYER  DE 
THE BOC GROUP  UK 
GLAXOSMITHKLINE  UK 
HENKEL  DE 
IMPERIAL CHEMICAL INDUSTRIES (ICI) UK 
KONINK DSM  NL 
L’ AIR LIQUIDE  FR 
MERCK  DE 
NOVARTIS  CH 
NOVO NORDISK  DK 
ROCHE HOLDING  CH 
SANOFI AVENTIS DE/FR 
SCHERING  DE 
SOLVAY BE 
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